Zaloguj się

Gotowe bibliografie tematyczne / Antimycobacterial susceptibility testing

Spis treści

Artykuły w czasopismach
Książki

Gotowa bibliografia na temat „Antimycobacterial susceptibility testing”

Autor: Grafiati

Data publikacji: 3 czerwca 2025

Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Antimycobacterial susceptibility testing”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Antimycobacterial susceptibility testing"

1

Griffith, M. E., and H. L. Bodily. "Stability of antimycobacterial drugs in susceptibility testing." Antimicrobial Agents and Chemotherapy 36, no. 11 (1992): 2398–402. http://dx.doi.org/10.1128/aac.36.11.2398.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Sánchez, Juan Gabriel Bueno, and Vladimir V. Kouznetsov. "Antimycobacterial susceptibility testing methods for natural products research." Brazilian Journal of Microbiology 41, no. 2 (2010): 270–77. http://dx.doi.org/10.1590/s1517-83822010000200001.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Inderlied, C. B. "Antimycobacterial susceptibility testing: Present practices and future trends." European Journal of Clinical Microbiology & Infectious Diseases 13, no. 11 (1994): 980–93. http://dx.doi.org/10.1007/bf02111499.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

K, Kalaiselvi, Mangayarkarasi V, Gomathi Ns, Balaji S, Shivshankar R. Mane, and Raja Shunmugam. "LUCIFERASE REPORTER MYCOBACTERIOPHAGES FOR EVALUATING NORBORNENE-BASED ANTITUBERCULOSIS DRUG SUSCEPTIBILITY TESTING ON MYCOBACTERIUM TUBERCULOSIS." Asian Journal of Pharmaceutical and Clinical Research 10, no. 9 (2017): 406. http://dx.doi.org/10.22159/ajpcr.2017.v10i9.19660.

Pełny tekst źródła

Streszczenie:

Objective: In 2015, 9.6 million people around the world became sick with tuberculosis (TB) disease and 1.5 million TB-related deaths worldwide. Recent increasing incidence of multidrug-resistant (MDR; resistance to at least rifampicin (RIF) and isoniazid [INH]) and extensively drug-resistant (MDR resistance plus resistance to a fluoroquinolone and an aminoglycoside) makes TB a serious concern. Lot of research is needed to deal with this infectious disease for a better alternative in treatment or modification of these older TB drugs. The present study aimed at evaluating antimycobacterial activ

Style APA, Harvard, Vancouver, ISO itp.

5

Washington, J. A. "Functions and activities of the Area Committee on Microbiology of the National Committee for Clinical Laboratory Standards." Clinical Microbiology Reviews 4, no. 2 (1991): 150–55. http://dx.doi.org/10.1128/cmr.4.2.150.

Pełny tekst źródła

Streszczenie:

The Area Committee on Microbiology of the National Committee for Clinical Laboratory Standards has responsibility for the development of guidelines and standards in the field of clinical microbiology. Through the consensus process, representatives from government, industry, and professional societies have developed standards on antibacterial susceptibility testing (M2, M7, and M11), antimycobacterial susceptibility testing (M24), quality assurance on commercially prepared microbiological culture media (M22), evaluation of production lots of dehydrated Mueller-Hinton agar (M6), and preparation

Style APA, Harvard, Vancouver, ISO itp.

6

Moore, Andrea V., Scott M. Kirk, Steven M. Callister, Gerald H. Mazurek, and Ronald F. Schell. "Safe Determination of Susceptibility of Mycobacterium tuberculosis to Antimycobacterial Agents by Flow Cytometry." Journal of Clinical Microbiology 37, no. 3 (1999): 479–83. http://dx.doi.org/10.1128/jcm.37.3.479-483.1999.

Pełny tekst źródła

Streszczenie:

We showed previously that susceptibility testing forMycobacterium tuberculosis labeled with fluorescein diacetate could be accomplished rapidly by using flow cytometry. However, safety was a major concern because mycobacteria were not killed prior to flow cytometric analysis. In this study, we developed a biologically safe flow cytometric susceptibility test that depends on detection and enumeration of actively growing M. tuberculosis organisms in drug-free and antimycobacterial agent-containing medium. The susceptibilities of 17 clinical isolates of M. tuberculosis to ethambutol, isoniazid, a

Style APA, Harvard, Vancouver, ISO itp.

7

Schoutrop, Esther L. M., Michelle A. E. Brouwer, Josien C. A. Jenniskens, et al. "The stability of antimycobacterial drugs in media used for drug susceptibility testing." Diagnostic Microbiology and Infectious Disease 92, no. 4 (2018): 305–8. http://dx.doi.org/10.1016/j.diagmicrobio.2018.06.015.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Singh, Ashok K., Shailendra K. Singh, Kavita Dhariyal, Ram Kumar, Amarendra Kumar, and Sudheer K. Singh. "Synthesis, Characterization and Antimycobacterial Activity of Phenanthrenequinone Thiosemicarbazones and their Ruthenium and Zinc Complexes." Asian Journal of Chemistry 33, no. 5 (2021): 983–88. http://dx.doi.org/10.14233/ajchem.2021.23127.

Pełny tekst źródła

Streszczenie:

The substituted phenanthrenequinone thiosemicarbazones (HL1, HL2 and HL3), and their metal complexes (M = Ru(II) or Zn(II); SM1, SM2, SM3 and SM4) were synthesized and characterized by FT-IR, 1H & 13C NMR and ESI-MS. The spectral data IR, 1H & 13C NMR and ESI-MS indicates two tridentate ligands coordinating in the form of an octahedral geometry. The gas phase geometry of all the zinc(II) and ruthenium(II) complexes was carried by using density functional theory (DFT). The antimycobacterial susceptibility testing at 100 μM of the complexes using resazurin microtiter plate assay resulted

Style APA, Harvard, Vancouver, ISO itp.

9

Sankar, Manimuthu, Krishnamoorthy Gopinath, Roopak Singla, and Sarman Singh. "In-vitro antimycobacterial drug susceptibility testing of non-tubercular mycobacteria by tetrazolium microplate assay." Annals of Clinical Microbiology and Antimicrobials 7, no. 1 (2008): 15. http://dx.doi.org/10.1186/1476-0711-7-15.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Guay, David RP. "Nontuberculous Mycobacterial Infections." Annals of Pharmacotherapy 30, no. 7-8 (1996): 819–30. http://dx.doi.org/10.1177/106002809603000721.

Pełny tekst źródła

Streszczenie:

OBJECTIVE: To review the epidemiology, clinical manifestations, diagnosis, and treatment of nontuberculous mycobacterial infections other than Mycobacterium avium complex (MAC). DATA SOURCES: A MEDLINE search of English-language literature pertaining to nontuberculous mycobacteria other than MAC was performed. Additional literature was obtained from reference lists of pertinent articles identified through the search. STUDY SELECTION AND DATA EXTRACTION: All articles were considered for possible inclusion in the review. Information judged by the author to be pertinent was selected for discussio

Style APA, Harvard, Vancouver, ISO itp.

Więcej źródeł

Książki na temat "Antimycobacterial susceptibility testing"

1

Antimycobacterial Susceptibility Testing Proposed Standard (Nccls Document M24-P). NCCLC, 1990.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!